cinoxacin has been researched along with Recrudescence in 14 studies
Cinoxacin: Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
cinoxacin : A member of the class of cinnolines that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We gave cinoxacin to 125 patients with initial and recurrent urinary tract infections to investigate the safety and efficacy of this new antimicrobial agent." | 9.05 | Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy. ( Cox, CE; Simmons, JR, 1982) |
| "In the TMP group one recurrence and in the CNO group two recurrences occurred during treatment, two recurrences being observed in each group during the follow-up period of 4-6 weeks." | 6.66 | Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections. ( Seppänen, J, 1988) |
| "Cinoxacin was as effective as trimethoprim-sulfamethoxazole without the emergence of resistant bacteria associated with trimethoprim-sulfamethoxazole." | 6.65 | Comparison of cinoxacin and trimethoprim-sulfamethoxazole in the treatment of urinary tract infections. ( Flynn, S; Jones, J; Schaeffer, AJ, 1981) |
| "Cinoxacin is an oral synthetic antibacterial agent, of the second generation quinolones group, with excellent efficacy in respiratory, intra-abdominal, pelvic, and skin and soft tissue infections." | 5.32 | Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. ( Emiliani, F; Quercia, O; Rafanelli, S; Stefanini, GF, 2003) |
| "A randomized clinical study was conducted in order to compare the effectiveness of norfloxacin and cinoxacin in complicated urinary tract infections." | 5.06 | [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract]. ( Cristiano, P; Della Vittoria Scarpati, M; Iovene, MR; Manguso, L; Morelli, G; Simioli, F, 1989) |
| "We gave cinoxacin to 125 patients with initial and recurrent urinary tract infections to investigate the safety and efficacy of this new antimicrobial agent." | 5.05 | Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy. ( Cox, CE; Simmons, JR, 1982) |
| "In the TMP group one recurrence and in the CNO group two recurrences occurred during treatment, two recurrences being observed in each group during the follow-up period of 4-6 weeks." | 2.66 | Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections. ( Seppänen, J, 1988) |
| "cinoxacin were compared to 1 g." | 2.65 | A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection. ( Bucy, JG, 1981) |
| "Cinoxacin was as effective as trimethoprim-sulfamethoxazole without the emergence of resistant bacteria associated with trimethoprim-sulfamethoxazole." | 2.65 | Comparison of cinoxacin and trimethoprim-sulfamethoxazole in the treatment of urinary tract infections. ( Flynn, S; Jones, J; Schaeffer, AJ, 1981) |
| "Cinoxacin is an oral synthetic antibacterial agent, of the second generation quinolones group, with excellent efficacy in respiratory, intra-abdominal, pelvic, and skin and soft tissue infections." | 1.32 | Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. ( Emiliani, F; Quercia, O; Rafanelli, S; Stefanini, GF, 2003) |
| "Ninety-seven patients with a history of recurrent bacteriuria were treated with cinoxacin in a dosage of either 250 mg (48 patients) or 500 mg (49 patients) 12-hourly for seven days." | 1.27 | Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection. ( Bax, R; Brumfitt, W; Hamilton-Miller, JM; Smith, GW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (92.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quercia, O | 1 |
| Rafanelli, S | 1 |
| Emiliani, F | 1 |
| Stefanini, GF | 1 |
| Scheckler, WE | 1 |
| Burt, RA | 1 |
| Paulson, DF | 1 |
| Landes, RR | 2 |
| Bucy, JG | 1 |
| Cox, CE | 1 |
| Simmons, JR | 1 |
| Schaeffer, AJ | 2 |
| Jones, JM | 1 |
| Flynn, SS | 1 |
| Finkelstein, LH | 1 |
| Arsht, DB | 1 |
| Manfrey, SJ | 1 |
| Flynn, S | 1 |
| Jones, J | 1 |
| Cristiano, P | 1 |
| Morelli, G | 1 |
| Simioli, F | 1 |
| Iovene, MR | 1 |
| Della Vittoria Scarpati, M | 1 |
| Manguso, L | 1 |
| Seppänen, J | 1 |
| Pfau, A | 1 |
| Sacks, TG | 1 |
| Shapiro, M | 1 |
| Nihira, H | 1 |
| Nakano, H | 1 |
| Brumfitt, W | 1 |
| Smith, GW | 1 |
| Hamilton-Miller, JM | 1 |
| Bax, R | 1 |
1 review available for cinoxacin and Recrudescence
| Article | Year |
|---|---|
[Prevention of recurrence of repetitious urinary tract infections in women].
Topics: Cinoxacin; Female; Humans; Pyridazines; Recurrence; Sex Factors; Urinary Tract Infections | 1986 |
7 trials available for cinoxacin and Recrudescence
| Article | Year |
|---|---|
Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections.
Topics: Adult; Aged; Cinoxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; | 1982 |
Cinoxacin for treatment and prevention of recurrent urinary tract infection.
Topics: Amoxicillin; Bacteria; Bacterial Infections; Cinoxacin; Clinical Trials as Topic; Double-Blind Metho | 1981 |
A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
Topics: Adult; Central Nervous System Diseases; Cinoxacin; Clinical Trials as Topic; Escherichia coli Infect | 1981 |
Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Cinoxacin; Clinical Trials as Topic; Female | 1982 |
Comparison of cinoxacin and trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
Topics: Adult; Cinoxacin; Drug Combinations; Drug Resistance; Enterobacteriaceae; Enterobacteriaceae Infecti | 1981 |
[Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
Topics: Bacteria; Bacteriuria; Cinoxacin; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Male; Mi | 1989 |
Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.
Topics: Adolescent; Adult; Cinoxacin; Double-Blind Method; Female; Humans; Middle Aged; Pyridazines; Random | 1988 |
6 other studies available for cinoxacin and Recrudescence
| Article | Year |
|---|---|
Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction.
Topics: 4-Quinolones; Anaphylaxis; Anti-Infective Agents; Cinoxacin; Double-Blind Method; Humans; Inflammati | 2003 |
Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora.
Topics: Adult; Aged; Bacteriuria; Cinoxacin; Drug Evaluation; Feces; Female; Humans; Middle Aged; Pyridazine | 1982 |
Cinoxacin and trimethoprim with sulfamethoxazole in the treatment of infections of the urinary tract: a clinical comparison.
Topics: Adult; Aged; Bacterial Infections; Cinoxacin; Drug Combinations; Drug Evaluation; Female; Humans; Ma | 1982 |
Long-term low dose cinoxacin therapy for the prevention of recurrent urinary tract infections.
Topics: Adult; Cinoxacin; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Pilot Pro | 1980 |
Prevention of recurrent urinary tract infections in premenopausal women by post-coital administration of cinoxacin.
Topics: Adult; Cinoxacin; Coitus; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; | 1988 |
Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.
Topics: Adult; Cinoxacin; Humans; Microbial Sensitivity Tests; Middle Aged; Pyridazines; Recurrence; Urinary | 1985 |